Vancouver, Canada (May 13, 2022) – Innovation and differentiation continue to propel precision prescribing software company GenXys with accolades and commercial success in the US market. GenXys recently was named the 2022 Best Overall Medical Data Solution Provider by MedTech Breakthrough Awards, which recognizes the...
Pharmacogenetic Testing & EHR Integration Help Avoid Trial-and-Error Prescribing Vancouver, Canada (April 21, 2022): GenXys Health Care Systems, Inc., the global leader in precision prescribing software with embedded pharmacogenetic data, added a record five pharmacogenetic companies as customers in the first quarter of 2022. The unprecedented...
Adverse Drug Events (ADEs) annually account for more than 1 million emergency department visits, 2.2 million hospital admissions, 3.5 million physician office visits, and $136 billion in U.S. health care costs. In addition to being the #1 most costly hospital-acquired condition, ADEs are also the...
This update accounts for revisions made to existing clinical guidelines and will help health care providers select the safest and most effective medications with their patients. This update follows the recommendations from the 2019 American College of Rheumatology Foundation Guideline for the Management of Osteoarthritis...
All TreatGx users now have access to the updated treatment algorithm for Chronic Obstructive Pulmonary Disease (COPD) – Stable. As always, this update includes the TreatGx standard of providing personalized dosing based on any applicable pharmacogenetics, kidney function, liver function, and drug interactions. This update was...
References 1 - https://www.futuremedicine.com/doi/10.2217/pgs-2019-0134 2 - https://www.cdc.gov/medicationsafety/adult_adversedrugevents.html 3 - https://bmchealthservres.biomedcentral.com/articles/10.1186/1472-6963-14-73 4 - https://pubmed.ncbi.nlm.nih.gov/24798722/ 5 - https://www.fda.gov/drugs/science-and-research-drugs/table-pharmacogenomic-biomarkers-drug-labeling 6 - https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0255642 7 - https://www.reuters.com/article/us-bristol-myers-sanofi-plavix-idUSKBN2AF1YI 8 - https://www.einnews.com/pr_news/560810526/pharmacogenomics-market-is-estimated-to-reach-usd-11-97-billion-by-2028-emergen-research#:~:text=RESEARCH%20%2D%20EIN%20Presswire-,Pharmacogenomics%20Market%20is%20estimated%20to%20reach,billion%20by%202028%3A%20EMERGEN%20RESEARCH&text=Pharmacogenomics%20Market%20trends%20%E2%80%93%20Growing%20demand%20for%20personalized%20therapy...
All TreatGx users now have access to the updated treatment algorithm for Migraine Prophylaxis. This update accounts for revisions made to existing clinical guidelines and will help health care providers select the safest and most effective medications with their patients. The algorithm now includes recommendations from...
All TreatGx users now have access to the updated treatment algorithm for Chronic Heart Failure. As always, these updates include the TreatGx standard of providing personalized dosing based on pharmacogenetics, kidney function, liver function, and drug interactions. This update includes recommendations from the 2021 Update to...
General Update GenXys is one of the first groups to update our comprehensive precision prescribing algorithm to include the latest release from the Clinical Pharmacogenetics Implementation Consortium (CPIC) CYP2C19 Genotype and Clopidogrel Therapy, published January 19, 2022. We stay at the cutting-edge of research and are constantly...
All TreatGx users now have access to the updated treatment algorithm for ADHD. ADHD This update accounts for revisions made to existing clinical guidelines and will help health care providers select the safest and most effective medications with their patients. This update follows the recommendations from ADHD...
